Capital DailyCapital Daily
Markets · Investing · Business
Capital DailyCapital Daily
Finance

Is SpaceX Your Ticket to Becoming a Millionaire?

Analysts are projecting immense growth for the newly public company. Could it mint new millionaires?

Is SpaceX Your Ticket to Becoming a Millionaire?

Published July 18, 2026 · Category: Finance

Overview

Space Exploration Technologies (NASDAQ: SPCX) has lost almost $1 trillion in notional value since its stock peaked in the initial days following its initial public offer (IPO). As of this writing on July 16, the stock (also known as SpaceX) is trading near its initial public offering (IPO) price of $135, about $133 the last time I checked.

If you watched this stock hit about $201 at the end of its third trading day, you might be wondering if this is the chance to buy in. Raymond James, which co-managed SpaceX's IPO, recently set a $800 price target on the space stock. Even the average price target, about $244, implies 83% upside.

Details

Even if the $800 price target materialized, it would take a very large investment for SpaceX to mint new millionaires: about $166,250 at today's price. Obviously, not every investor has six figures to invest with, nor would it be prudent to put that much into a stock that still trades at about 100 times sales. The question then becomes: Even if SpaceX alone can't make you a millionaire, can it be one of several stocks that you pick that contributes to millionaire status?

Continue reading

Source

Originally published at www.fool.com.

Related Articles

CD
Capital Daily Newsroom

Capital Daily covers markets, crypto and commodities for Asia & the Middle East — tier-1 desk research, AI-driven analysis, institutional-grade data. Tip our newsroom: [email protected]

Email the newsroom →
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.